Universitätsklinikum Tübingen

Hospital


Location: Tübingen, Germany (DE) DE

ISNI: 0000000101968249

ROR: https://ror.org/00pjgxh97

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Pravention und Berufskrankheit (2020) Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article Malformationen des Zentralnervensystems - Seltene Ursachen eines organischen Wachstumshormonmangels bei Kindern (2020) Dörr HG, Bettendorf M, Binder G, Hauffa B, Mohnike K, Mueller HL, Reinehr T, et al. Journal article S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators (2020) Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren (2020) Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast) (2020) Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, Gravis G, et al. Conference contribution Carboplatin/Pegylated Liposomal Doxorubicin/Bevacizumab (CD-Bev) vs. Carboplatin/Gemcitabine/Bevacizumab (CG-BEV) in Patients with Recurrent Ovarian Cancer: a Prospective Randomized Phase iii Engot/GCiG-Intergroup Study (Ago Study Group, Ago-AUSTRiA, ANZGOG,GiNECO, SGCTG) (2020) Hanker L, Harter P, Sehoul L, Rau J, Canzler U, Schmalfeldt B, Thiel F, et al. Conference contribution First Results of the Detect IVA Study -Everolimus Treatment in Patients with HER2-Negative, Hormone-Receptor Positive Metastatic Breast (MBC) Cancer and Circulating Tumor Cells (CTC) (2020) Friedl TWP, Krause S, Fasching P, Schneeweiss A, Mueller V, Riethdorf S, Taran FA, et al. Conference contribution Medizinische Betreuung von jungen Frauen mit Ullrich-Turner-Syndrom in Deutschland (2020) Dörr HG, Bettendorf M, Binder G, Braemswig J, Hauffa BP, Holterhus PM, Mohnike K, et al. Journal article Scleroderma renal crisis: Risk factors for an increasingly rare organ complication (2020) Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, et al. Journal article A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, et al. Journal article